Latest Updates on INSY
-
marijuana industry 3 Simple Ways to Profit from California's Legal Cannabis Market
The Golden State officially legalized marijuana on Jan. 1. But don't worry - it's not too late to profit from California's legal cannabis market. Read more » -
penny stocks 10 Top Biotech Penny Stocks to Watch for September 2017
Today, we're showing you the top biotech penny stocks to watch for September 2017. These include the top performers of August, two of which climbed more than 100% last month. Read more » -
stocks The Best Marijuana Stock to Buy Could Gain 92% and Fight the Opioid Crisis
The opioid crisis is worsening in the United States, with an estimated 100 people dying every day from it. But marijuana companies are starting to realize cannabis can help reduce the number of opioid overdoses. Read more » -
stocks These 3 Marijuana Stocks Have Minted Our Readers Gains Up to 990% - and Counting
Marijuana stocks are making our readers rich. Read more » -
penny stocks What Are the Top Pharmaceutical Penny Stocks of August 2017?
Today, we're showing you the top pharmaceutical penny stocks of August 2017. Many of these companies have posted gains above 25%, with the top performer up 49.2%. Read more » -
Stocks 3 Biotech Stocks to Buy Now for Gains Up to 93%
Finding the best biotech stocks to buy now can be exhausting, especially when investors have to read pages of technical jargon to find out what each company does. That's why we've made it easy for Money Morning readers. Read more » -
stocks These 2 Biotech Companies Are Cashing In on Medical Marijuana in 2017, and So Can You
The two biotech companies we're recommending today are expected to cash in big with medical marijuana. The stocks of both biotech companies are expected to gain at least 25% in the next 12 months because of their new marijuana-based drugs. Read more » -
stocks One of the Best Biotech Stocks of 2017 Could See 130% Gains This Year
One of the best biotech stocks this year is positioned to cash in on the convergence of two major trends in the biotech industry. This convergence could propel the stock to gains of as much as 130% in the next 12 months. Read more » -
stocks Biotech Stocks 2017: The Best Way to Beat the Market This Year
Biotech stocks in 2017 are beating the markets with nearly double the gains of the Dow. And the biotech sector is expected to continue beating the markets this year. But not all biotech stocks are worth the investment. Picking the right … Read more » -
stocks The Best Pharmaceutical Stock in 2017 Could Double Your Money
The pharmaceutical industry is expected to see spending in the sector double in the next few years. The best pharmaceutical stock in 2017 is set to cash in on the increased spending by taking advantage of the medical marijuana trends. Read more » -
stocks 3 "Cheap" Biotech Stocks to Buy Now for Gains as High as 180%
Tag Page Excerpt: These cheap biotech stocks to buy could gain as much as 180% in the next 12 months. Their rapid stock price gains are largely due to the new drugs these companies are releasing. Read more » -
Stocks One of the Best Biotech Stocks in 2017 Could Double Your Money
One of the best biotech stocks in 2017 could double in price in the next 12 months or less. And that might just be the beginning, depending on how its newest drug performs on the market and how its pipeline treatments perform in ongoing … Read more » -
Stocks Insys Therapeutics Stock Gave Us a 26% Return in Just 12 Days... and That's Only the Start
Despite the recent negative news, Insys Therapeutics stock is still a great buy. Even better for investors is the fact that it has an upcoming catalyst that is going to send the price per share soaring. Read more » -
biotechnology How Mylan Stole $1.27 Billion from Taxpayers and Rewarded Its Top Execs
Once again, a Big Pharma company has rewarded its top execs at the expense of shareholders... Mylan overcharged the government (a.k.a. the taxpayers) for EpiPen distribution by over a billion dollars. Read more » -
Biotechnology Our "War on Pain" Biotech Put You Up by Double Digits in Just Two Weeks
Insys Therapeutics - our "War on Pain" biotech play - has given us a profit of more than 10.7% since we recommended the stock a little less than two weeks ago. I hope you like profits, because that's just for starters. The U.S. Food … Read more »
